PeerVoice Clinical Pharmacology Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 19m. Bisher sind 436 Folge(n) erschienen. Dieser Podcast erscheint alle 4 Tage.

Gesamtlänge aller Episoden: 6 days 23 hours

subscribe
share





Personalising Care Across the Disease Continuum: From Prediabetes Through Type 2 Diabetes


Personalising Care Across the Disease Continuum: From Prediabetes Through Type 2 Diabetes


share







 2021-08-07  44m
 
 

Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights From the 2021 Virtual ERA-EDTA Congress


Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights From the 2021 Virtual ERA-EDTA Congress


share







 2021-07-17  8m
 
 

Identifying Bowel Urgency in Patients With Ulcerative Colitis: The Need for Speed


Identifying Bowel Urgency in Patients With Ulcerative Colitis: The Need for Speed


share







 2021-07-16  59m
 
 

Suspecting, Diagnosing and Managing Multifocal Motor Neuropathy: A Patient Investigation


Suspecting, Diagnosing and Managing Multifocal Motor Neuropathy: A Patient Investigation


share







 2021-07-16  49m
 
 

Immunotherapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Which Antibodies for Which Patients?


Immunotherapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Which Antibodies for Which Patients?


share







 2021-07-13  58m
 
 

Going the Distance in HIV: Simplifying ART at Every Stage


Going the Distance in HIV: Simplifying ART at Every Stage


share







 2021-06-29  24m
 
 

Checkpoint Inhibitors for Advanced or Recurrent Endometrial Cancer: A New Standard of Care?


Checkpoint Inhibitors for Advanced or Recurrent Endometrial Cancer: A New Standard of Care?


share







 2021-06-26  26m
 
 

If I'd Known Then What I Know Now: Recognising My First AHP Patient


If I'd Known Then What I Know Now: Recognising My First AHP Patient


share







 2021-06-25  18m
 
 

Evaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021


Evaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021


share







 2021-06-24  8m
 
 

Easy to Treat vs Easy to Manage Patients With HCV: What’s the Difference?


Easy to Treat vs Easy to Manage Patients With HCV: What’s the Difference?


share







 2021-06-23  29m